-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Aho1O+vTw89PuWxb4PSsvTboqc1emxOIZKG42cYI3hf3POriUUH/4rO+8Zsk5uP1 uboo9deHHaUifaCIpRFssA== 0000019617-08-000384.txt : 20080822 0000019617-08-000384.hdr.sgml : 20080822 20080822173015 ACCESSION NUMBER: 0000019617-08-000384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080731 FILED AS OF DATE: 20080822 DATE AS OF CHANGE: 20080822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALPHARMA INC CENTRAL INDEX KEY: 0000730469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222095212 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 440 ROUTE 22 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-566-3800 MAIL ADDRESS: STREET 1: 440 ROUTE 22 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: A L PHARMA DATE OF NAME CHANGE: 19960513 FORMER COMPANY: FORMER CONFORMED NAME: A L LABORATORIES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: J P MORGAN CHASE & CO CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08593 FILM NUMBER: 081035263 BUSINESS ADDRESS: STREET 1: 270 PARK AVE STREET 2: 39TH FL CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 MAIL ADDRESS: STREET 1: 270 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER NAME: FORMER CONFORMED NAME: CHASE MANHATTAN CORP /DE/ DATE OF NAME CHANGE: 19960402 FORMER NAME: FORMER CONFORMED NAME: CHEMICAL BANKING CORP DATE OF NAME CHANGE: 19920703 FORMER NAME: FORMER CONFORMED NAME: CHEMICAL NEW YORK CORP DATE OF NAME CHANGE: 19880508 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2008-07-31 1 0000730469 ALPHARMA INC ALO US 0000019617 J P MORGAN CHASE & CO 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 Common Stock, par value $0.01/share 2008-07-31 4 S 0 200 22.72 D 4212480 I See Footnotes Common Stock, par value $0.01/share 2008-08-01 4 S 0 100 21.92 D 4212380 I See Footnotes Common Stock, par value $0.01/share 2008-08-01 4 P 0 300 21.8967 A 4212680 I See Footnotes Common Stock, par value $0.01/share 2008-08-04 4 S 0 200 21.58 D 4212480 I See Footnotes Common Stock, par value $0.01/share 2008-08-05 4 P 0 300 23.1367 A 4212780 I See Footnotes Common Stock, par value $0.01/share 2008-08-06 4 P 0 300 23.2667 A 4213080 I See Footnotes Common Stock, par value $0.01/share 2008-08-08 4 P 0 100 23.48 A 4213180 I See Footnotes Common Stock, par value $0.01/share 2008-08-08 4 S 0 289 24.29 D 4212891 I See Footnotes Common Stock, par value $0.01/share 2008-08-11 4 P 0 600 25.0883 A 4213491 I See Footnotes Common Stock, par value $0.01/share 2008-08-11 4 S 0 89 25 A 4213402 I See Footnotes Common Stock, par value $0.01/share 2008-08-12 4 P 0 400 24.785 A 4213802 I See Footnotes Common Stock, par value $0.01/share 2008-08-12 4 S 0 50 24.85 D 4213752 I See Footnotes Common Stock, par value $0.01/share 2008-08-14 4 P 0 702 23.8903 A 4214454 I See Footnotes Common Stock, par value $0.01/share 2008-08-15 4 P 0 368 24.2321 A 4214822 I See Footnotes Common Stock, par value $0.01/share 2008-08-15 4 S 0 100 23.93 A 4214722 I See Footnotes Common Stock, par value $0.01/share 2008-08-18 4 S 0 1000 24.197 D 4213722 I See Footnotes Common Stock, par value $0.01/share 2008-08-18 4 S 0 8300 24.2574 A 4205422 I See Footnotes Common Stock, par value $0.01/share 2008-08-18 4 S 0 12700 24.39 D 4192722 I See Footnotes Common Stock, par value $0.01/share 2008-08-19 4 S 0 446 24.0564 D 4192276 I See Footnotes Common Stock, par value $0.01/share 2008-08-19 4 S 0 17000 23.8363 D 4175276 I See Footnotes (1) This Form 4 amends the Form 4 previously filed by J.P. Morgan Ventures Corporation (a wholly-owned subsidiary of the reporting person) on 8/20/08 by including transactions effected by other wholly-owned subsidiaries of the reporting person which were mistakenly not included on the prior Form 4. (2) Beneficial ownership of these shares was acquired in varying amounts by the following wholly-owned subsidiaries of the reporting person: J.P. Morgan Ventures Corporation, J.P. Morgan Securities Inc., J.P. Morgan Whitefriars Inc., and The Bear Stearns Companies LLC. JPMorgan Chase & Co. expressly disclaims beneficial ownership of such shares except to the extent of its respective pecuniary interest in such shares. Anthony Horan 2008-08-22 -----END PRIVACY-ENHANCED MESSAGE-----